TC BioPharm Ltd - TCBP Net Assets per Single Share

Graphic logo of TC Biopharm (TCBP)

Geopolitical sanctions and logistical disruptions between Britain and the rest of the world are slowing the development of anti-cancer agents. The GURU.Markets platform features this chart of the book value per common share for TC Biopharm (TCBP), where 2.00 indicates the current level. TC Biopharm (TCBP) is developing patent-protected T-cell therapy against leukemia while awaiting FDA data, maintaining key immunologists through a system of stock options and grants.

TC BioPharm (Holdings) Plc (TCBP): Share Book Value from 04/28/2023 to 03/29/2025

tcbiopharm.com - analytical breakdowns and key metrics (TCBP)

- price and consensus price forecast:
Stock Price TC BioPharm (Holdings) PLC|TCBP - Price Target Chart
- market capitalization data:
Market Value TC BioPharm (Holdings) Plc|TCBP - Full Business Value
- book capitalization data:
Net Assets per Single Share TC BioPharm|TCBP - Net Asset Value|Market Capitalization to Book Value Ratio tcbiopharm.com|TCBP - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital TC Biopharm|TCBP - Long-Term Debt to Capital|Short-Term Debt to Equity TC BioPharm|TCBP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio TC BioPharm (Holdings) Plc
Fundamental company valuation:TC BioPharm (Holdings) PLC - TCBP
Manufactured products of TC BioPharm

TC Biopharm focuses on protecting its R&D competencies in cell therapy by retaining key immunologists. The book value per share measures the business's net assets, allowing investors to assess the company's asset base; meanwhile, the horizontal trend of the book value per share indicates stagnant accumulated capital and a temporary lull in the company's operational expansion.

Competitors of TC Biopharm (TCBP)

ARGX - Book Value per Share|BNTX: Net Assets per Single Share|Net Assets per Single Share Abivax Corp (ABVX)|ADMA (admabiologics.com) - Share Book Value|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|ANAB - Net Asset Value per Share|Accounting Value per Share Astria Pharma ATXS|ENGN - Book Price of a Share|RAPT (RAPT Therapeutics, Inc.) - Book Value per Share|Accounting Value per Share Aerovate Therapeutics|ACRS - Accounting Value per Share|Accounting Value of a Share Kyverna Therapeutics Inc.|Book Value per Share Tiziana Life Sciences PLC (TLSA)|Net Assets per Single Share Cabaletta Bio Inc (CABA)|Book Value per Share VTYX|theratech.com - Net Assets per Share|AVTX (Avalo Therapeutics) - Net Assets per Single Share|ELDN: Net Asset Value per Share|Net Assets per Single Share Agenus Inc (AGEN)|Climb Bio, Inc (CLYM) - Share Book Value|ZURA - Book Value per Share|Accounting Value of a Share atyrpharma.com|Book Value per Share ADAG|Book Value per Share IMA (ikenaoncology.com)|Net Assets per Single Share Shattuck Labs|Equillium Inc - Accounting Value of a Share|CNTB: Net Assets per Single Share|Immunic, Inc. (IMUX) - Accounting Value per Share|ATRA - Accounting Value per Share|InflaRx (IFRX) - Book Price of a Share|Book Value per Share XFOR|Accounting Value per Share Adicet|Book Value per Share Celularity Inc. (CELU)|Net Assets per Single Share INMB (inmunebio.com)|Barinthus Biotherapeutics plc (BRNS) - Net Assets per Single Share|Kezar Life Sciences Inc. - Share Book Value|Net Assets per Single Share SAB Biotherapeutics, Inc|AKTX - Share Book Value|Book Value per Share enlivex.com ENLV|Q32 Bio (QTTB) - Accounting Value of a Share|GOVX (GeoVax) - Book Value per Share|Book Value per Share EDSA|iBio Corp (IBIO) - Net Assets per Single Share|Accounting Value of a Share CARM (carismatx.com)|XTL Biopharmaceuticals - Net Assets per Single Share|Accounting Value per Share Bolt Biotherapeutics Inc. BOLT|HCW Biologics Inc - Book Value per Share|Aptevo Therapeutics (APVO) - Book Value per Share|Accounting Value per Share AIM ImmunoTech AIM|Aditxt, Inc. (ADTX) - Accounting Value of a Share|GRI: Book Value per Share|Net Assets per Share XRTX|Net Assets per Single Share HIND (Vyome Holdings)|Accounting Value per Share REVB (Revelation Biosciences Inc)|Indaptus - Net Assets per Single Share|SCNI - Accounting Value per Share|CalciMedica Corp - Accounting Value per Share|AFMD: Book Value per Share|Net Assets per Single Share allakos.com|HOOKIPA Pharma (HOOK) - Equity per Share|Book Value per Share IGMS (IGM Biosciences Inc.)|Net Asset Value per Share iTeos Pharma (ITOS)|Accounting Value per Share Ocean Biomedical, Inc.|Book Price of a Share thirdharmonicbio.com (THRD)